Physician

Russell Scott Rowe, MD

According to 2025 Medicare claims, Russell Rowe, MD (NPI: 1215026232) practices dermatology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is RUSSELL ROWE, MD, PA (NPI: 1922658897; TIN: 834712822) and primary practice location at 76712-6143. Rowe is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rowe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,005 traditional Medicare patients, billed 10,962 HCPCS/CPT codes, and received $1,249,804 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,001 prescription claims across 453 beneficiaries totaling $720,542 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 66 records totaling $2,014. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $97,549 to $1,249,804. Similarly, Part D prescription costs have risen steadily, from $21,442 to $720,542. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$647K$1.3M2015 Medicare payment: $97,549 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $374,081 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $417,699 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $478,226 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $136,809 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $315,089 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $551,702 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $898,081 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,294,225 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,249,804 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153582,069$97,549
20161,0027,848$374,081
20171,0378,269$417,699
20189748,091$478,226
20196262,948$136,809
20207335,984$315,089
20219146,448$551,702
20221,0538,256$898,081
20231,07711,732$1,294,225
20241,00510,962$1,249,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$360K$721K2015 Drug cost: $21,442 (USD; Tot_Drug_Cst)2016 Drug cost: $97,976 (USD; Tot_Drug_Cst)2017 Drug cost: $243,590 (USD; Tot_Drug_Cst)2018 Drug cost: $203,485 (USD; Tot_Drug_Cst)2019 Drug cost: $138,459 (USD; Tot_Drug_Cst)2020 Drug cost: $195,797 (USD; Tot_Drug_Cst)2021 Drug cost: $190,353 (USD; Tot_Drug_Cst)2022 Drug cost: $268,017 (USD; Tot_Drug_Cst)2023 Drug cost: $354,201 (USD; Tot_Drug_Cst)2024 Drug cost: $720,542 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015123265$21,442
2016340870$97,976
2017341913$243,590
2018378971$203,485
2019251526$138,459
2020334807$195,797
2021362865$190,353
2022434896$268,017
2023377893$354,201
20244531,001$720,542

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths341425$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6711,108$61
11102Biopsy of related skin growth, first growth331385$58
17000Destruction of precancer skin growth, 1 growth554817$34
17003Destruction of precancer skin growth, 2-14 growths4112,521$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa211,708$424,646
RinvoqUpadacitinib21690$140,355
Clobetasol PropionateClobetasol Propionate942,592$3,227
KetoconazoleKetoconazole1795,199$3,014
Triamcinolone AcetonideTriamcinolone Acetonide2276,663$2,567

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.66$2,014Kerecis Limited
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Russell Scott Rowe, MD?

Tedicare shows public-source Medicare data for Russell Scott Rowe, MD (NPI 1215026232), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Russell Scott Rowe, MD have ACO affiliation data?

Russell Scott Rowe, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Russell Scott Rowe, MD?

Russell Scott Rowe, MD is linked to RUSSELL ROWE, MD, PA (billing NPI 1922658897) in the available physician profile data.

Does Russell Scott Rowe, MD have Open Payments data?

Russell Scott Rowe, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.